Neurologic clinical trial -Ensure-2

Neurologic

Status:

Open/Enrolling

ClinicalTrials.gov:

NCT05201638

Ensure-2 

Drug

IMU-838

Phase

Phase III

Condition

Relapsing Multiple Sclerosis

Keywords

Relapsing Multiple Sclerosis | Multiple Sclerosis | MS | RMS

Reach out about this clinical trial

Researcher

Todd Levine